A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates

Kaltenbach, T.; Friedland, S.; Soetikno, R.
October 2008
Gut;Oct2008, Vol. 57 Issue 10, p1406
Academic Journal
Objective: Colonoscopy, the "gold standard" screening test for colorectal cancer (CRC), has known diagnostic limitations. Advances in endoscope technology have focused on improving mucosal visualisation. In addition to increased angle of view and resolution features, recent colonoscopes have non-white-light optics, such as narrow band imaging (NBI), to enhance image contrast. We aimed to study the neoplasia diagnostic characteristics of NBI, by comparing the neoplasm miss rate when the colonoscopy was performed under NBI versus white light (WL). Design: Randomised controlled trial. Setting: US Veterans hospital. Patients: Elective colonoscopy adults. Intervention: We randomly assigned patients to undergo a colonoscopic examination using N8l or WL. All patients underwent a second examination using WL, as the reference standard. Main outcome measures: The primary end point was the difference in the neoplasm miss rate, and secondary outcome was the neoplasm detection rate. Results: In 276 tandem colonoscopy patients, there was no significant difference of miss or detection rates between NBI or WL colonoscopy techniques. Of the 135 patients in the NBI group, 17 patients (12.6%; 95% confidence interval (Cl) 7.5 to 19.4%) had a missed neoplasm, as compared with 17 of the 141 patients (12.1%; 95% Cl 7.2 to 18.6%) in the WL group, with a miss rate risk difference of 0.5% (95% Cl -7.2 to 8.3). 130 patients (47%) had at least one neoplasm. Missed lesions with NBI showed similar characteristics to those missed with WL. All missed neoplasms were tubular adenomas, the majority (78%) was ⩽ 5 mm and none were larger than 1 cm (one-sided 95% Cl up to 1%). Nonpolypoid lesions represented 35% (13/37) of missed neoplasms. Interpretation: NBI did not improve the colorectal neoplasm miss rate compared to WL; the miss rate for advanced adenomas was less than 1% and for all adenomas was 12%. The neoplasm detection rates were similar high using NBI or WL; almost a half the study patients had at least one adenoma. Clinicaltrials.gov identifier: NCT00628147


Related Articles

  • Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis. Castleberry, A.; Güller, U.; Tarantino, I.; Berry, M.; Brügger, L.; Warschkow, R.; Cerny, T.; Mantyh, C.; Candinas, D.; Worni, M. // Journal of Gastrointestinal Surgery;Jun2014, Vol. 18 Issue 6, p1194 

    Purpose: Recently, multiple clinical trials have demonstrated improved outcomes in patients with metastatic colorectal cancer. This study investigated if the improved survival is race dependent. Patients and Methods: Overall and cancer-specific survival of 77,490 White and Black patients with...

  • Quality Assurance Through Outcome Registration in Colorectal Cancer: An ECCO Initiative for Europe. van Gijn, Willem; van de Velde, Cornelis J. H. // European Journal of Clinical & Medical Oncology;2011, Vol. 3 Issue 3, p1 

    In recent years there have been significant improvements in the outcome of rectal cancer treatment. Both new surgical techniques as well as effective neoadjuvant treatment regimens have contributed to these improvements. It is key to spread these advances toward every rectal cancer patient and...

  • Impact of a Family History of Colorectal Cancer on the Prevalence of Advanced Neoplasia at Colonoscopy in 4,967 Asymptomatic Patients. Tsai, Franklin; Strum, Williamson // Digestive Diseases & Sciences;Dec2012, Vol. 57 Issue 12, p3234 

    Background and Aims: A family history of colorectal cancer is considered an independent risk factor for advanced neoplasia at colonoscopy. The expected outcome for screening colonoscopy in patients with a family history is not well established in all populations. Methods: We designed a large,...

  • Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUV) guide us in the timing of colonoscopy? Hoeij, F.; Keijsers, R.; Loffeld, B.; Dun, G.; Stadhouders, P.; Weusten, B. // European Journal of Nuclear Medicine & Molecular Imaging;Jan2015, Vol. 42 Issue 1, p66 

    Purpose: In patients undergoing F-FDG PET/CT, incidental colonic focal lesions can be indicative of inflammatory, premalignant or malignant lesions. The maximum standardized uptake value (SUV) of these lesions, representing the FDG uptake intensity, might be helpful in differentiating malignant...

  • Adenoma detection with cap-assisted colonoscopy versus regular colonoscopy: a randomised controlled trial. de Wijkerslooth, Thomas R.; Stoop, Esther M.; Bossuyt, Patrick M.; Mathus-Vliegen, Elisabeth M. H.; Dees, Jan; J. Tytgat, Kristien M. A.; van Leerdam, Monique E.; Fockens, Paul; Kuipers, Ernst J.; Dekker, Evelien // Gut;Oct2012, Vol. 61 Issue 10, p1426 

    Objective Conventional colonoscopy (CC) is considered the reference standard for detection of colorectal neoplasia, but it can still miss a substantial number of adenomas. The use of a transparent plastic cap may improve colonic visualisation. Cap-assisted colonoscopy (CAC) was compared with CC...

  • Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy. Keefe, Dorothy; Elting, Linda; Nguyen, Hoang; Grunberg, Steven; Aprile, Giuseppe; Bonaventura, Antony; Selva-Nayagam, Sudarsha; Barsevick, Andrea; Koczwara, Bogda; Sonis, Stephen // Cancer Chemotherapy & Pharmacology;Oct2014, Vol. 74 Issue 4, p675 

    Background: Diarrhea is a common toxicity of chemotherapy, but the practice of reporting only severe grades (≥ 3) in clinical trials results in misleading conclusions of significance. Epidemiology remains poorly described, and effects of multi-cycle regimens have not been investigated. To...

  • Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. D. Papamichael; R. Audisio; J.-C. Horiot; B. Glimelius; J. Sastre; E. Mitry; E. Van Cutsem; M. Gosney; C.-H. Köhne; M. Aapro // Annals of Oncology;Jan2009, Vol. 20 Issue 1, p5 

    Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximately half the incidence occurring in patients >70 years of age. Elderly CRC patients, however, are understaged, undertreated and underrepresented in clinical trials. The International Society of...

  • Folic Acid for the Prevention of Colorectal Adenomas. Cole, Bernard F.; Baron, John A.; Sandler, Robert S.; Haile, Robert W.; Ahnen, Dennis J.; Bresalier, Robert S.; McKeown-Eyssen, Gail; Summers, Robert W.; Rothstein, Richard I.; Burke, Carol A.; Snover, Dale C.; Church, Timothy R.; Allen, John I.; Robertson, Douglas J.; Beck, Gerald J.; Bond, John H.; Byers, Tim; Mandel, Jack S.; Mott, Leila A.; Pearson, Loretta H. // JAMA: Journal of the American Medical Association;6/6/2007, Vol. 297 Issue 21, p2351 

    This article presents research on the use of folic acid for the prevention of colorectal adenomas. The object of the study was to assess the safety and efficacy of folic acid supplements for preventing colorectal adenomas. The study found that folic acid a 1mg/d does not reduce colorectal...

  • Prone Positioning of Obese Patients for Colonoscopy Results in Shortened Cecal Intubation Times: A Randomized Trial. Uddin, Fatema; Iqbal, Ramiz; Harford, William; Dunbar, Kerry; Cryer, Byron; Spechler, Stuart; Feagins, Linda // Digestive Diseases & Sciences;Mar2013, Vol. 58 Issue 3, p782 

    Background: Obesity is a risk factor for colorectal cancer, and colonoscopy can be technically challenging in obese patients. It has been proposed (with little supporting data) that prone positioning of obese patients might facilitate a difficult colonoscopy. Aim: The aim of this study was to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics